Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369421 · ClinicalTrials.gov registry record
Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
A clinical trial of Arterial Calcification Due to Deficiency of CD73, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT00369421: Recruiting study of Arterial Calcification Due to Deficiency of CD73, sponsored by National Human Genome Research Institute (NHGRI).
NCT00369421 is a study of Arterial Calcification Due to Deficiency of CD73 that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 4,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00369421, a study of Arterial Calcification Due to Deficiency of CD73, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be examined and treated on an out patient basis, if practical. However, patients requiring specialized tests or treatments will be admitted to the NIH Clinical Center as necessary. Researchers will use only accepted medical procedures in diagnosing (medical history, physical examinations, X-ray studies, eye examinations, blood tests, and urine tests) and treating the patients involved in this study. Additional tests may be required on a case to case basis. Many patients seen in this study will go on to be enrolled in a specific disease-related research study.\<TAB\>
Primary Outcome
Clinical characterization.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1978-09-12 |
What NCT00369421 shows while recruiting
NCT00369421 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Arterial Calcification Due to Deficiency of CD73 appearing as the primary indexed condition, and to 0 interventions.
NCT00369421 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00369421 about?
NCT00369421 is a clinical study titled "Diagnosis and Treatment of Patients With Inborn Errors of Metabolism". Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be ...
What is the current status of trial NCT00369421?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 1978-09-12.
What conditions does trial NCT00369421 study?
This clinical trial studies the following conditions: Arterial Calcification Due to Deficiency of CD73.
Who is sponsoring clinical trial NCT00369421?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00369421 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI